The latest report, titled ‘Global Antimicrobial Susceptibility Testing/ Antibiotic Sensitivity Testing Market ,’ comprises a profound analysis of the fundamental parameters contributing to the global Antimicrobial Susceptibility Testing/ Antibiotic Sensitivity Testing market scenario. The research report provides the reader with an in-depth interpretation of the Antimicrobial Susceptibility Testing/ Antibiotic Sensitivity Testing market dynamics, including the crucial drivers, opportunities, threats, and challenges. The report also describes the key business strategies, demand and supply ratios, leading regions, and the renowned market players, in a nutshell, offering a futuristic outlook of the overall Antimicrobial Susceptibility Testing/ Antibiotic Sensitivity Testing industry.
The global antimicrobial susceptibility testing market is projected to be worth USD 4,587.1 Million by 2027, according to a current analysis by Emergen Research. The antimicrobial/antibiotic susceptibility testing/antibiotic sensitivity testing market is observing high demand attributed to the growing prevalence of the infectious disease. Emerging infectious diseases pose a substantial burden on public health and economies worldwide and are considered to be triggered essentially by socio-economic, ecological, and environmental factors. The recent outbreak of the COVID-19 pandemic dramatically has raised cognizance of the worldwide burden of infectious disease and about the readiness of public health systems to combat the spread of such diseases.
The SWOT analysis and Porter’s Five Forces Analysis are some of the most important components of this report that provide insight into the highly competitive environment of the industry. A detailed analysis of the global Antimicrobial Susceptibility Testing/ Antibiotic Sensitivity Testing market is presented in the report, including North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. Aside from revenue growth drivers & restraints, production & consumption patterns, changing consumer preferences, and stringent regulatory standards, this report also examines other key aspects of regional markets.
Market Dynamics:
The report offers insightful information about the market dynamics of the Antimicrobial Susceptibility Testing/ Antibiotic Sensitivity Testing market. It offers SWOT analysis, PESTEL analysis, and Porter’s Five Forces analysis to present a better understanding of the Antimicrobial Susceptibility Testing/ Antibiotic Sensitivity Testing market, competitive landscape, factors affecting it, and to predict the growth of the industry. It also offers the impact of various market factors along with the effects of the regulatory framework on the growth of the Antimicrobial Susceptibility Testing/ Antibiotic Sensitivity Testing market.
To receive a sample copy of this report, visit @ https://www.emergenresearch.com/request-sample/381
Target Audience of the Global Antimicrobial Susceptibility Testing/ Antibiotic Sensitivity Testing Market Report:
- Key Market Players
- Investors
- Venture capitalists
- Small- and medium-sized and large enterprises
- Third-party knowledge providers
- Value-Added Resellers (VARs)
- Global market producers, distributors, traders, and suppliers
- Research organizations, consulting companies, and various alliances interested in this sector
- Government bodies, independent regulatory authorities, and policymakers
Major Geographies Analyzed in the Report:
- North America (U.S., Canada)
- Europe (U.K., Italy, Germany, France, Rest of EU)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Leading manufacturers profiled in the report:
Danaher Corporation, Merck KGaA, HiMedia Laboratories, Bruker Corporation, BioMerieux SA, Bio-Rad Laboratories, Precise Automation, Roche Diagnostics, Accelerate Diagnostics Inc., Becton, Dickinson, and Company
Some Key Highlights From the Report
- On 15 August 2022, a global commercial partnership deal was announced by BD, a significant global healthcare technology company, and Accelerate Diagnostics, Inc., a pioneer in rapid in-vitro microbiology diagnostics. As per the conditions of the contract, BD will give Accelerate access to its hourly results-based quick testing system for antibiotic susceptibility and resistance, as compared to one to two days with certain traditional laboratory techniques.
- Antibacterial susceptibility testing segment is expected to account for largest revenue share over the forecast period, owing to an increase in number of individuals who are multi-drug resistant as a result of overusing wide-spectrum antibiotics. In developing countries, the incidence of resistant microorganisms, which make healthcare-associated infections (HAIs) more challenging to treat, is also on the rise globally.
- Automated susceptibility testing instruments segment is expected to account for largest revenue share during the forecast period. Simplicity, automation, and compactness makes AST a widely used diagnostic tool. Computer integration has made online analysis and data interchange feasible, which is a substantial improvement for results validation, especially at faraway locations. Additionally, market revenue growth is being driven by new product releases by major companies in the industry and expanding Research and Development (R&D) initiatives.
- Market in North America is expected to account for largest revenue share during the forecast period. One of the major factors driving revenue growth of the market in this region is technological advancements in antimicrobial susceptibility products. For instance, Accelerate Diagnostics, Inc. stated on 7 July 2021, that the Accelerate PhenoTest BC kit was available in the US in a new IVD format. According to this development, the organization now provides two choices for fast sepsis testing. It has been shown that the Accelerate Pheno system greatly improves clinical outcomes, such as the time it takes to get results, time it takes to get the best treatment, how long therapy lasts, and how long a patient must stay in hospital.
Market Segmentation by Product Type:
Component Outlook (Revenue, USD Billion; 2017-2027)
- Manual Antimicrobial Susceptibility Testing Products
- Automated Laboratory Instruments
- Culture & Growth Media
- Consumables
Type Outlook (Revenue, USD Billion; 2017-2027)
- Antibacterial Susceptibility Testing
- Antiparasitic Susceptibility Testing
- Antifungal Susceptibility Testing
- Others
Application Outlook (Revenue, USD Billion; 2017-2027)
- Drug Discovery & Development
- Clinical Diagnostics
- Epidemiology
- Others
Research Report on the Antimicrobial Susceptibility Testing/ Antibiotic Sensitivity Testing Market Addresses the Following Key Questions:
- Who are the dominant players of the Antimicrobial Susceptibility Testing/ Antibiotic Sensitivity Testing market?
- Which regional market is anticipated to have a high growth rate over the projected period?
- What consumer trends and demands are expected to influence the operations of the market players in the Antimicrobial Susceptibility Testing/ Antibiotic Sensitivity Testing market?
- What are the key growth drivers and restraining factors of the Antimicrobial Susceptibility Testing/ Antibiotic Sensitivity Testing market?
- What are the expansion plans and strategic investment plans undertaken by the players to gain a robust footing in the market?
- What is the overall impact of the COVID-19 pandemic on the Antimicrobial Susceptibility Testing/ Antibiotic Sensitivity Testing market and its key segments?
Thank you for reading our report. Customization of the report is available according to the requirements of our clients. Kindly get in touch with us to know more about the customization options, and our team will ensure the report is tailored according to your needs.
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
